Beamer Edward, Gölöncsér Flóra, Horváth Gergely, Bekő Katinka, Otrokocsi Lilla, Koványi Bence, Sperlágh Beáta
Laboratory of Molecular Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1450 Budapest, Hungary.
Laboratory of Molecular Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1450 Budapest, Hungary.
Neuropharmacology. 2016 May;104:94-104. doi: 10.1016/j.neuropharm.2015.09.019. Epub 2015 Sep 16.
The principle functions of neuroinflammation are to limit tissue damage and promote tissue repair in response to pathogens or injury. While neuroinflammation has utility, pathophysiological inflammatory responses, to some extent, underlie almost all neuropathology. Understanding the mechanisms that control the three stages of inflammation (initiation, propagation and resolution) is therefore of critical importance for developing treatments for diseases of the central nervous system. The purinergic signaling system, involving adenosine, ATP and other purines, plus a host of P1 and P2 receptor subtypes, controls inflammatory responses in complex ways. Activation of the inflammasome, leading to release of pro-inflammatory cytokines, activation and migration of microglia and altered astroglial function are key regulators of the neuroinflammatory response. Here, we review the role of P1 and P2 receptors in mediating these processes and examine their contribution to disorders of the nervous system. Firstly, we give an overview of the concept of neuroinflammation. We then discuss the contribution of P2X, P2Y and P1 receptors to the underlying processes, including a discussion of cross-talk between these different pathways. Finally, we give an overview of the current understanding of purinergic contributions to neuroinflammation in the context of specific disorders of the central nervous system, with special emphasis on neuropsychiatric disorders, characterized by chronic low grade inflammation or maternal inflammation. An understanding of the important purinergic contribution to neuroinflammation underlying neuropathology is likely to be a necessary step towards the development of effective interventions. This article is part of the Special Issue entitled 'Purines in Neurodegeneration and Neuroregeneration'.
神经炎症的主要功能是在病原体或损伤的刺激下限制组织损伤并促进组织修复。虽然神经炎症具有一定作用,但病理生理炎症反应在某种程度上几乎是所有神经病理学的基础。因此,了解控制炎症三个阶段(起始、传播和消退)的机制对于开发中枢神经系统疾病的治疗方法至关重要。嘌呤能信号系统涉及腺苷、三磷酸腺苷(ATP)和其他嘌呤,以及众多P1和P2受体亚型,以复杂的方式控制炎症反应。炎性小体的激活导致促炎细胞因子的释放、小胶质细胞的激活和迁移以及星形胶质细胞功能的改变,是神经炎症反应的关键调节因素。在此,我们综述P1和P2受体在介导这些过程中的作用,并研究它们对神经系统疾病的影响。首先,我们概述神经炎症的概念。然后,我们讨论P2X、P2Y和P1受体对相关过程的影响,包括对这些不同途径之间相互作用的讨论。最后,我们概述在中枢神经系统特定疾病背景下,目前对嘌呤能对神经炎症作用的理解,特别强调以慢性低度炎症或母体炎症为特征的神经精神疾病。了解嘌呤能在神经病理学基础的神经炎症中的重要作用可能是开发有效干预措施的必要步骤。本文是名为“神经退行性变和神经再生中的嘌呤”特刊的一部分。